Protagonist Therapeutics, Inc: cashflow_financing

Value{"amount": 18285000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Period2022-01-01 – 2022-09-30
Statuscurrent
EntityProtagonist Therapeutics, Inc
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001558370-22-016908
Retrieved: 2026-08-19T13:14:38.425290+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001377121/cashflow-financing/2022-09-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/77f56186-68f6-48a0-8011-e1e49fc172e2

History